Literature DB >> 15561869

Polymorphism in plasmodium falciparum drug transporter proteins and reversal of in vitro chloroquine resistance by a 9,10-dihydroethanoanthracene derivative.

Julie Millet1, Sandrine Alibert, Marylin Torrentino-Madamet, Christophe Rogier, Christiane Santelli-Rouvier, Patricia Bigot, Joel Mosnier, Eric Baret, Jacques Barbe, Daniel Parzy, Bruno Pradines.   

Abstract

BG958 reverses resistance in chloroquine-resistant isolates from different countries. Five mutations in the Plasmodium falciparum crt (pfcrt) gene resulting in the amino acid changes K76T, M74I, N75E, A220S, and R371I are systematically identified in resistance-reversed Asian, African, and Brazilian parasites which possess the pfcrt (CIET) haplotype. In combination with BG958, the activity of chloroquine is increased in parasites with the N86Y mutation in pfmdr1.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15561869      PMCID： PMC529231          DOI： 10.1128/AAC.48.12.4869-4872.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  33 in total

1.  Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum.

Authors:  R Durand; S Jafari; J Vauzelle; J F Delabre; Z Jesic; J Le Bras
Journal:  Mol Biochem Parasitol       Date:  2001-04-25       Impact factor: 1.759

2.  Lysosomes and drug resistance in malaria.

Authors:  David C Warhurst; John C Craig; Ipemida S Adagu
Journal:  Lancet       Date:  2002-11-16       Impact factor: 79.321

3.  In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine.

Authors:  A M Oduola; A Sowunmi; W K Milhous; T G Brewer; D E Kyle; L Gerena; R N Rossan; L A Salako; B G Schuster
Journal:  Am J Trop Med Hyg       Date:  1998-05       Impact factor: 2.345

4.  Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin.

Authors:  Martha Kalkanidis; Nectarios Klonis; Leann Tilley; Leslie W Deady
Journal:  Biochem Pharmacol       Date:  2002-03-01       Impact factor: 5.858

5.  Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine.

Authors:  A J Bitonti; A Sjoerdsma; P P McCann; D E Kyle; A M Oduola; R N Rossan; W K Milhous; D E Davidson
Journal:  Science       Date:  1988-12-02       Impact factor: 47.728

6.  Synthesis and effects on chloroquine susceptibility in Plasmodium falciparum of a series of new dihydroanthracene derivatives.

Authors:  Sandrine Alibert; Christiane Santelli-Rouvier; Bruno Pradines; Carole Houdoin; Daniel Parzy; Janina Karolak-Wojciechowska; Jacques Barbe
Journal:  J Med Chem       Date:  2002-07-18       Impact factor: 7.446

7.  Reversal of chloroquine resistance in Plasmodium falciparum by verapamil.

Authors:  S K Martin; A M Oduola; W K Milhous
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

8.  Reversal of chloroquine resistance in falciparum malaria.

Authors:  J C Ryall
Journal:  Parasitol Today       Date:  1987-08

9.  Prevalence of the K76T mutation in the pfcrt gene of Plasmodium falciparum among chloroquine responders in India.

Authors:  Sumiti Vinayak; Sukla Biswas; Vas Dev; Ashwani Kumar; M A Ansari; Y D Sharma
Journal:  Acta Trop       Date:  2003-07       Impact factor: 3.112

10.  In vitro increase in chloroquine accumulation induced by dihydroethano- and ethenoanthracene derivatives in Plasmodium falciparum-parasitized erythrocytes.

Authors:  Bruno Pradines; Sandrine Alibert; Carole Houdoin; Christiane Santelli-Rouvier; Joel Mosnier; Thierry Fusai; Christophe Rogier; Jacques Barbe; Daniel Parzy
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191
View more
  5 in total

1.  Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.

Authors:  Fabián E Sáenz; Tina Mutka; Kenneth Udenze; Ayoade M J Oduola; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2012-06-18       Impact factor: 5.191

2.  Genetic architecture of artemisinin-resistant Plasmodium falciparum.

Authors:  Olivo Miotto; Roberto Amato; Elizabeth A Ashley; Bronwyn MacInnis; Jacob Almagro-Garcia; Chanaki Amaratunga; Pharath Lim; Daniel Mead; Samuel O Oyola; Mehul Dhorda; Mallika Imwong; Charles Woodrow; Magnus Manske; Jim Stalker; Eleanor Drury; Susana Campino; Lucas Amenga-Etego; Thuy-Nhien Nguyen Thanh; Hien Tinh Tran; Pascal Ringwald; Delia Bethell; Francois Nosten; Aung Pyae Phyo; Sasithon Pukrittayakamee; Kesinee Chotivanich; Char Meng Chuor; Chea Nguon; Seila Suon; Sokunthea Sreng; Paul N Newton; Mayfong Mayxay; Maniphone Khanthavong; Bouasy Hongvanthong; Ye Htut; Kay Thwe Han; Myat Phone Kyaw; Md Abul Faiz; Caterina I Fanello; Marie Onyamboko; Olugbenga A Mokuolu; Christopher G Jacob; Shannon Takala-Harrison; Christopher V Plowe; Nicholas P Day; Arjen M Dondorp; Chris C A Spencer; Gilean McVean; Rick M Fairhurst; Nicholas J White; Dominic P Kwiatkowski
Journal:  Nat Genet       Date:  2015-01-19       Impact factor: 38.330

3.  Unexpected selections of Plasmodium falciparum polymorphisms in previously treatment-naïve areas after monthly presumptive administration of three different anti-malarial drugs in Liberia 1976-78.

Authors:  Irina T Jovel; Anders Björkman; Cally Roper; Andreas Mårtensson; Johan Ursing
Journal:  Malar J       Date:  2017-03-13       Impact factor: 2.979

4.  Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure.

Authors:  Wassim Daher; Christophe Biot; Thierry Fandeur; Helene Jouin; Lydie Pelinski; Eric Viscogliosi; Laurent Fraisse; Bruno Pradines; Jacques Brocard; Jamal Khalife; Daniel Dive
Journal:  Malar J       Date:  2006-02-07       Impact factor: 2.979

5.  Antiplasmodial and trypanocidal activity of violacein and deoxyviolacein produced from synthetic operons.

Authors:  Elizabeth Bilsland; Tatyana A Tavella; Renata Krogh; Jamie E Stokes; Annabelle Roberts; James Ajioka; David R Spring; Adriano D Andricopulo; Fabio T M Costa; Stephen G Oliver
Journal:  BMC Biotechnol       Date:  2018-04-11       Impact factor: 2.563
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.